Co-Diagnostics Inc — Cash Flow (NASDAQ:CODX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 28.17 M41.08 M6.57 M-22.08 M-29.16 M -31.17 M Cash from investing activities 5.82 M4.1 M-58.17 M15.39 M17.07 M 26.87 M Cash from financing activities 19.74 M450.4 K-14.03 M-1.36 M103.91 K 4.95 M Free cash flow 27.39 M40.41 M5.14 M-23.45 M-29.9 M -31.81 M

Nachrichten

Will Community Health's $450M Hospital Divestment Reduce Debt Burden?

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.80%

Co-Diagnostics droht Delisting von der NASDAQ – Handel soll im OTC-Markt fortgesetzt werden

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform

Aktie von Co-Diagnostics bricht nach Ankündigung einer Aktienzusammenlegung ein

Co-Diagnostics stock plunges after announcing 1-for-30 reverse split

Co-Diagnostics kündigt Aktienzusammenlegung im Verhältnis 1 zu 30 an

Co-Diagnostics announces 1-for-30 reverse stock split

Co-Diagnostics erhält australisches Patent für PCR-Testplattform

Co-diagnostics receives Australian patent for PCR testing platform